Newswire (Published: Wednesday, April 12, 2017, Received: Thursday, April 6, 2017, 3:54:44 PM CDT)

Word Count: 387

By a News Reporter-Staff News Editor at Biotech Week -- Research findings on Transplant Medicine - Kidney Transplants are discussed in a new report. According to news originating from Chicago, Illinois, by NewsRx correspondents, research stated, "As patients with end-stage renal disease are receiving renal allografts at older ages, the number of male renal transplant recipients (RTRs) being diagnosed with prostate cancer (CaP) is increasing. Historically, the literature regarding the management of CaP in RTR's is limited to case reports and small case series."

Our news journalists obtained a quote from the research from Rush University Medical Center, "To date, there are no standardized guidelines for screening or management of CaP in these complex patients. To better understand the unique characteristics of CaP in the renal transplant population, we performed a literature review of PubMed, without date limitations, using a combination of search terms including prostate cancer, end stage renal disease, renal transplantation, prostate cancer screening, prostate specific antigen kinetics, immunosuppression, prostatectomy, and radiation therapy. Of special note, teams facilitating the care of these complex patients must carefully and meticulously consider the altered anatomy for surgical and radiotherapeutic planning. Active surveillance, though gaining popularity in the general low risk prostate cancer population, needs further study in this group, as does the management of advance disease."

According to the news editors, the research concluded: "This review provides a comprehensive and contemporary understanding of the incidence, screening measures, risk stratification, and treatment options for CaP in RTRs."

For more information on this research see: Prostate cancer in renal transplant recipients. International Braz J Urol, 2017;43(): (see also Transplant Medicine - Kidney Transplants).

The news correspondents report that additional information may be obtained from B.A. Sherer, Dept. of Urology, Rush University Medical Center, Chicago, Illinois, United States. Additional authors for this research include K. Warrior, K. Godlewski, M. Hertl, O. Olaitan, A. Nehra and L.A Deane.

Keywords for this news article include: Biomedicine, Chicago, Surgery, Illinois, Oncology, Nephrology, Epidemiology, United States, Renal Disease, Prostate Cancer, Renal Allograft, Transplantation, Renal Transplant, Organ Transplants, Kidney Transplants, Prostatic Neoplasms, Transplant Medicine, North and Central America, Diagnostics and Screening.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

Companies

Rush University Medical Center

Industries

Healthcare
      Healthcare Facilities
            Hospitals

Places

Central America
North America
United States
Americas
Illinois
Chicago

Subjects

Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
            Cancer
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
            Urological Diseases
      Health Sciences
            Medical Research
                  Clinical Outcomes
      Medical Specialties and Practices
            Nephrology
            Radiology
            Urology
      Treatments and Therapies
            Biomaterials
            Transplants